Medical Evaluation Device for Secure Nebulizer Therapy Adherence

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional medical evaluation devices for aerosol nebulizers lack assurance of confidentiality and integrity of personal health data during transfer to central servers, and do not provide reliable feedback for adjusting therapy protocols securely.

Innovation Solution

A medical evaluation device that includes a communication unit for secure data transfer and an evaluation unit to assess adherence to therapy protocols, using a white list for identifying authorized communication devices and encrypting data, ensuring secure communication and feedback without exposing personal data.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If personal health data is transferred to central servers for medical evaluation, then medical evaluation capability is improved, but data confidentiality and integrity are compromised

Engineering Contradiction:
Improvemedical evaluation capabilityVSAvoiddata confidentiality and integrity
Core Design Contradiction:
Adaptability or versatilityVSObject-affected harmful factors

Solution Approach 1:

The patent extracts and removes personal health data from the transfer process. The medical evaluation device evaluates adherence to therapy protocols using anonymized or aggregated data characteristics without transferring identifiable personal health information to central servers, thus maintaining evaluation capability while protecting data confidentiality

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent introduces an intermediary processing layer between the aerosol nebulizer and central servers. The medical evaluation device acts as a mediator that processes data locally to extract evaluation-relevant information while removing personal identifiers before any potential transmission, thus enabling medical evaluation without compromising data integrity

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If data is encrypted and white list authentication is implemented, then data security is improved, but communication complexity increases

Engineering Contradiction:
Improvedata securityVSAvoidcommunication complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent implements preliminary authentication and encryption setup before actual data communication occurs. The white list of authorized communication devices is pre-configured and stored in the medical evaluation device, and encryption keys are established in advance, so that during operation only simple verification and encrypted transmission are needed, reducing real-time complexity

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent uses simplified authentication tokens or identifiers as copies of complex security credentials. Instead of transmitting or processing complex cryptographic keys during communication, the system uses pre-shared identification tokens that verify authorization without revealing the underlying security mechanisms, thus maintaining security while reducing communication complexity

Inventive Principle:
Principle #26Copying

Data Source

PatentEP3414687B1Medical evaluation device
Publication Date: 2023.12.06 PARI PHARMA GMBH
  • EP3414687B1 patent drawingFigure 1
  • EP3414687B1 patent drawingFigure 2
  • EP3414687B1 patent drawingFigure 3a

AI summary

The present invention relates to a medical evaluation device (10) for evaluating an adherence to a therapy protocol when using an aerosol nebulizer (30) having an aerosol generator (31) for nebulizing a liquid medication according to said therapy protocol, said medical evaluation device (10) comprising: a communication unit (100), configured to establish a communication connection with a communication device (20), said communication connection being configured for: providing first configuration data to a nebulizer control device (40) of said aerosol nebulizer (30) via said communication device (20), said first configuration data for configuring said aerosol nebulizer according to said therapy protocol; and receiving nebulizing data indicating an operation of said aerosol nebulizer from said communication device (20); further comprising an evaluation unit (110), configured to evaluate said adherence to said therapy protocol based on a comparison of said received nebulizing data with respective parameters defined within said therapy protocol; wherein said evaluation unit (110) is further configured to generate therapy related feedback data.